Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Ryan G. is listed as 🥇🥇🥇3x President’s Club Winner Startup & Launch | Rare Disease Advocate Be Real, Work Hard, Have Fun and Get it Done! at ITF Therapeutics LLC, based in Greater Sacramento, United States, United States. AeroLeads shows a matched LinkedIn profile for Ryan G..
Ryan G. previously worked as Key Account Manager at Itf Therapeutics Llc and Regional Account Manager - Alagille Syndrome (ALGS) at Mirum Pharmaceuticals. Ryan G. holds Bachelor Of Science - Bs, Business, Management, Marketing, And Related Support Services from California State University-Sacramento.
This section adds company-level context without repeating Ryan G.'s masked contact details.
Review company-level records connected to Ryan G. before choosing the right outreach path.
*3x President’s Club Award Winner. Consistent Top 25% in 20+ year long career in industry. Experienced rare/ultra rare disease consultant with documented sales success in both biotech startup and large integrated pharmaceutical organizations. Significant Product launches (10+) and field Hub reimbursement experience. A focus on demand generation and working between offices/HCP’s and aligned medical policy to secure reimbursement drug across medicaid and commercial payers. Significant reauthorization experience to ensure clinical criteria are met and continuation of therapy around aligned payer policy.Collaboration across function to support key account development initiatives from marketing, medical and caregiver advocacy. A diverse therapeutic background including small molecule, IV/subcu therapies, enzyme replacement therapy (ERT), and monoclonal antibodies/fragments.Strong clinical acumen to building a foundation of trust to educate providers on complex rare diseases with transformative therapies. Many are rare and variable in clinical and biochemical presentation requiring a strong clinical scientific acumen to engage KOLs and help families on their diagnostic odyssey. Significant market development and diagnostic experience, KOL/speaker development, as well as marketing to commercial insights experience.Existing Relationships and Call Points: Genetics, Pediatric and Adult Hepatology/Gastroenterology, Pediatric Endocrinology, Hematology/Oncology, Interventional and Noninvasive Cardiology, Lipidology, and Pulmonology.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Northern California / San Francisco Bay Area
*Launch and establish Duvyzat (Givinostat), a pan HDAC inhibitor indicated for the treatment of Duchenne Muscular Dystrophy in patients > 6 years of age.*Educate Pediatric Specialists and Key Neuromuscular Accounts on Duvyzat (givinostat) an emerging treatment option for patients with DMD, further broadening treatment options for patients at any stage of.
N CA | NV | OR | WA | HI | AK
Lead and establish Mirum as the foremost authority in the field of cholestatic liver disease by spearheading the promotion and recognition of Livmarli (Maralixibat), the first FDA-approved treatment for cholestatic pruritus of Alagille Syndrome in patients over 1 year of age. Conduct comprehensive pre-approval profiling of key accounts and transplant.
N. CA, Central Valley & Hawaii
Premarket and launch execution for two benign hematologic disorders, Cablivi (Caplacizumab IV, SC) and Cold Agglutinin Disease (CAD). Cablivi is a transformational treatment for acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening autoimmune blood disorder caused by a severe deficiency of the ADAMTS13 cleaving enzyme of Von.
N. CA, NV, OR, WA, ID, AK
Manager Key Academic Accounts and Centers of Excellence across a diverse 5 state region converting N. CA, WA, OR, NV, and AK. Proactively built awareness and provided comprehensive education on diagnosis and treatment for LAL-D and Hypophosphatasia, two ultra-rare, progressive, and life-threatening genetic disorders.Delivered specialized knowledge to.
San Francisco Bay Area
Institutional/Hospital Sales representative in launch of Praluent (Alirocumab) for patients not at LDL-C goal on statin therapy or statin intolerant and at high risk for ASCVD events. Developed inpatient protocols and discharge planning for patients in hospital.
San Francisco Bay Area
Pulmonary Arterial Hypertension WHO Group I covering the San Francisco Bay Area, Key academic centers and community education to raise awareness and appropriate diagnosis for Letairis (Ambrisentan, Endothelin Receptor Antagonist). Education to KOL’s on differential diagnosis of patients with WHO Group I. Cardiac Transplant Center, Academic Centers, Heart.
Sacramento, California, United States
Quick answers generated from the profile data available on this page.
Ryan G. works for ITF Therapeutics LLC.
Ryan G. is listed as 🥇🥇🥇3x President’s Club Winner Startup & Launch | Rare Disease Advocate Be Real, Work Hard, Have Fun and Get it Done! at ITF Therapeutics LLC.
Ryan G. is based in Greater Sacramento, United States, United States while working with ITF Therapeutics LLC.
Ryan G. has worked for Itf Therapeutics Llc, Mirum Pharmaceuticals, Sanofi Genzyme, Alexion Pharmaceuticals, Inc., and Regeneron Pharmaceuticals, Inc..
You can use AeroLeads to view verified contact signals for Ryan G. at ITF Therapeutics LLC, including work email, phone, and LinkedIn data when available.
Ryan G. holds Bachelor Of Science - Bs, Business, Management, Marketing, And Related Support Services from California State University-Sacramento.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Ryan G. you were looking for.
